BromhexIne And Spironolactone For CoronаVirUs Infection Requiring HospiTalization
NCT04424134
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
80
Enrollment
OTHER
Sponsor class
Conditions
COVID 19
Interventions
DRUG:
Bromhexine and Spironolactone
DRUG:
Base therapy
Sponsor
Lomonosov Moscow State University Medical Research and Educational Center